Latest news with #HealthcareProfessionals
CBC
23-05-2025
- General
- CBC
Learning Cree helps this dental hygienist connect with and treat her patients
A non-Indigenous dental hygienist in the northern Quebec community of Waskaganish is learning Cree in an effort to communicate more effectively with the people she serves. For the past six years, Camille Poirier has been filling her notebook with Cree words, sentences, and phrases. "I think that makes a difference because they know that you're there for many reasons, not only for work, but also to connect," said Poirier, who is originally from the Gatineau, Que. and Rockland, Ont. area. Poirier began working in Waskaganish after graduating from university. What was intended to be a temporary position became a new home for Poirier and her family. "I wanted to connect more with the patient like, and I find that with the language you can connect with the person because they understand you better," said Poirier. At the daycare, Poirier found that most children spoke Cree and the same with her teenage patients, leaving her to often rely on translation. "When I asked them a question in English, they always asked their parents in Cree. So I was like, I want to ask them so they can answer me," she said. Communication is not the only goal Poirier had. "So I was like, OK, how could I make them have more trust in me?" said Poirier. "So I started to learn a few key words. First I learned apaa st'uin so to open their mouth, chipaah st'uin, close your mouth and I would say akaawii aahchii, dont move, or brushoo chiitihpit anchiish, did you brush your teeth today?" Learning Cree also helped her connect with those around her. "The staff at the dental clinic were speaking together, laughing, and I wanted to laugh with them, I wanted to know what they were saying," said Poirier. Having learned Cree, Poirier can now understand and participate in her colleagues' conversations and laughter. "So now I'm always saying them. 'Be careful. I understand'," she said. Poirier is not the only one learning to speak Cree, her two-year-old daughter is picking up the language with her peers in daycare. "She speaks to me like ' aashtam, aashtam mommy' and she say ' namui ' when I ask her to do something," said Poirier. Aashtam means come here, which contrasts with the toddler's current favorite word, namui, which means no. Her toddler now recites her daycare snack time prayer at home before supper, among other phrases she has learned. Having lived in Waskaganish for nearly seven years, Poirier now considers it home. She actively engages in community traditions such as goose plucking and fishing, and she crafted her first pair of moose hide moccasins there. "I feel like I'm part of the community, and I feel accepted. I'm really happy about it because I really wanted to be here," said Poirier. She said she is still learning and wishes to continue expanding her knowledge, even beyond the pages of her book. "I cannot say that I'm fluent in Cree, but I would say that I manage," she said. "I want my book to be full."
Yahoo
16-05-2025
- Health
- Yahoo
Adult Vaccine Market Forecast Report 2025-2033: Increasing Geriatric Population and Immunosenescence, Increasing Government Vaccination Campaigns and Awareness, Advancements in Innovations
Adult Vaccine Market Dublin, May 16, 2025 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to Global Adult Vaccines Market was worth USD 21.77 billion in 2024 and is forecasted to hit USD 37.18 billion by the end of 2033 at a CAGR of 6.13% between 2025 and 2033. Demand for vaccines increases due to mounting awareness regarding immunization in adults, high disease incidence, and an ageing global population. Adult vaccines are the vaccines specifically for persons 18 years and above that are given to prevent disease from various infections. Although vaccination in childhood establishes initial immunity, adult immunization is important to sustain long-term health and ward off disease epidemics. Vaccines commonly recommended for adults are against influenza, hepatitis A and B, human papillomavirus (HPV), herpes zoster or shingles, pneumococcal disease, tetanus, and diphtheria. These vaccines are especially crucial for older adults, those with chronic diseases, healthcare personnel, and travelers. The demand for adult vaccines has increased across the world, particularly after the COVID-19 pandemic, which showed the importance of immunization among elderly people. Governments and health bodies increasingly advocate for adult immunization through increased awareness campaigns and standard health check-ups. Industrialized countries like Europe and North America have established adult vaccination programs, whereas developing economies in Asia-Pacific, Latin America, and the Middle East are building their public health infrastructure to enhance adult vaccine coverage. This change is generating robust global demand for adult Drivers in the Global Adult Vaccines Market Increasing Geriatric Population and ImmunosenescenceThe world population is growing old very fast, thus increasing the age-related diseases and a compromised immune system, which is referred to as immunosenescence. As people grow older, they become weaker in fighting infections, and immunization at the right time becomes necessary. Vaccines like influenza, shingles, and pneumococcal are most sought after among the elderly. By 2030, 1 in 6 individuals on the planet will be 60 years or older, with this age group growing from 1 billion in 2020 to 1.4 billion. By 2050, it will reach 2.1 billion, and those 80 and above will triple to 426 million. As a result, global healthcare systems are adding routine adult immunization to preventive care plans. This demographic shift is strongly propelling the demand for adult vaccines and motivating pharmaceutical firms to develop age-specific and more potent Government Vaccination Campaigns and AwarenessGovernments and global health agencies are stepping up efforts to promote adult immunization through awareness campaigns and subsidized vaccination programs. Programs like the CDC's adult immunization schedule and WHO's expanded immunization agenda are raising public awareness and acceptance of adult vaccines. These initiatives focus on preventing preventable hospitalizations, minimizing healthcare expenditures, and restraining the spread of preventable disease among adults. With supportive regulatory measures and increased public health focus, these initiatives are driving up higher vaccine penetration rates in developed and emerging economies, serving as a key market growth catalyst. World Immunization Week, which occurs during the fourth week of April 2025, encourages the value of immunization to safeguard all ages against vaccine-preventable diseases. The Vaccines National Strategic Plan 2021-2025 provides the U.S. vision for the elimination of these diseases within the next five in Vaccine Technology and InnovationInnovations in vaccine technology - recombinant DNA methods, mRNA platforms, and adjuvant systems - are improving vaccine efficacy, safety, and shelf life. These advances facilitate quicker production of adult-specific needs vaccines such as HPV, shingles, and flu. Further, the COVID-19 pandemic catapulted R&D spending and collaborations, which overtrickled into wider vaccine innovation. Pharmaceutical companies are currently concentrating on combination vaccines and multivalent adult vaccines with enhanced convenience and coverage. These technological leaps are opening up new opportunities in the global adult vaccines market, encouraging wider immunization across various adult age groups. April 2025, Uganda's Ministry of Health has confirmed the introduction of the R21/Matrix-MT malaria vaccine into routine immunization, making it the 19th African country to do so. The vaccine will first target 1.1 million children under the age of two in 105 high- and moderate-transmission districts, with nationwide rollout Adult Vaccines Market Challenges Vaccine Hesitancy and MisinformationDespite demonstrated efficacy, adult vaccination is resisted due to pervasive misinformation and doubt. Adult individuals downplay the danger of vaccine-preventable disease or feel immunization is solely needed during childhood. Social media sites frequently drive vaccine hesitancy by disseminating false information regarding side effects and safety. This resistance impedes uptake, particularly in low- and middle-income countries with poor health literacy. Addressing misinformation and enhancing trust in public health advice is critical to overcoming this obstacle and attaining widespread adult vaccine Costs and Restricted Access in Low-Income AreasAdult vaccines may be costly, especially in nations without universal healthcare coverage. In low-income areas, access to crucial vaccines is restricted because of poor infrastructure, lack of cold chain logistics, and prohibitive out-of-pocket expenses. In contrast to pediatric vaccines, that are subsidized or delivered through global schemes such as GAVI, adult immunization does not have a similar financing arrangement in most nations. Such an approach of financing and logistics hampers the distribution of vaccines as well as efforts to establish a robust adult immunization program, thus slowing market growth overall. Key Players Analysis: Overview, Key Persons, Recent Developments, Product Portfolio, Revenue GlaxoSmithKline, plc. AstraZeneca plc Sanofi Pasteur Pfizer, Inc. CSL Limited Bristol-Myers Squibb Company Pfizer Inc. Novarts AG Johnson & Johnson Eli Lily Company Seattle Genetics Inc Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $21.77 Billion Forecasted Market Value (USD) by 2033 $37.18 Billion Compound Annual Growth Rate 6.1% Regions Covered Global Key Topics Covered: 1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics4.1 Growth Driver4.2 Challenges5. Global Adult Vaccines Market5.1 Market5.2 Volume (people)6. Adult Vaccines Market & Numbers Share Analysis6.1 Adult Vaccine Market Share6.2 By Country Adult Vaccine Market Share6.3 Adult Vaccinated Population Share7. Disease wise - Adult Vaccines Market7.1 Influenza7.2 Cervical Cancer (HPV)7.3 Zoster (Shingles)7.4 MMR (Measles, Mumps, and Rubella Vaccine)7.5 Pneumococcal7.6 Meningococcal7.7 Hepatitis7.8 TdaP7.9 Travel and Miscellaneous7.10 Varicella8. Disease wise - Numbers of Vaccinated Adults8.1 Influenza8.2 Cervical Cancer (HPV)8.3 Zoster (Shingles)8.4 MMR8.5 Pneumococcal8.6 Meningococcal8.7 Hepatitis8.8 TdaP8.9 Varicella9. Country9.1 North America9.1.1 United States9.1.2 Canada9.2 Europe9.2.1 United Kingdom9.2.2 Germany9.2.3 France9.2.4 Russia9.2.5 Italy9.2.6 Spain9.2.7 Switzerland9.3 Asia-Pacific9.3.1 India9.3.2 China9.3.3 Japan9.3.4 Australia9.3.5 South Korea9.4 Latin Africa9.4.1 Mexico9.4.2 Brazil9.4.3 Argentina9.5 Middle East and Africa9.5.1 Saudi Arabia9.5.2 UAE9.5.3 South Africa9.6 Rest of the World10. Porter's Five Forces10.1 Bargaining Power of Buyers10.2 Bargaining Power of Suppliers10.3 Degree of Competition10.4 Threat of New Entrants10.5 Threat of Substitutes11. SWOT Analysis11.1 Strengths11.2 Weaknesses11.3 Opportunities11.4 Threats12. Mergers and Acquisitions in the Vaccine Industry13. Vaccines and Regulator's Interventions13.1 Making and Meeting Standards of Quality and Safety13.2 Vaccine Funding14. Vaccines - Products and Pipeline14.1 GSK Vaccine Product Pipeline14.2 AstraZeneca plc Vaccine Product Pipeline14.3 Sanofi Vaccine Product Pipeline14.4 Pfizer Vaccine Product Pipeline15. Vaccines Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Adult Vaccine Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CTV News
10-05-2025
- Health
- CTV News
Rural physician shortage sparks debate over incentives, systemic fixes
Sault Ste. Marie Mayor Matthew Shoemaker wants the province to prohibit communities from offering incentives to doctors to move to their town or city.
